Gracecast Lung Cancer Audio
ASCO 2012 LC Highlights: Dr. Mark Socinski on Single Agent vs Doublet Chemo for PS2 (audio)
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:06:50
- Mas informaciones
Informações:
Sinopsis
Dr. Mark Socinski from the University of Pittsburgh reviews evidence to support doublet chemo over single agent for marginal performance status (PS2) patients with advanced NSCLC.
